Loading...
Publication
Estudo da perda de osteointegração de implantes dentários em pacientes medicados com SSRI
| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 5.36 MB | Adobe PDF |
Authors
Advisor(s)
Abstract(s)
A depressão, uma condição de saúde mental que tem despertado uma crescente preocupação global devido ao seu impacto significativo na qualidade de vida, saúde física e bem-estar emocional das pessoas. Paralelamente, observa-se cada vez mais um aumento de perda de dentes, devido à negligência dos cuidados de saúde oral associada à apatia decorrente da depressão. O aumento do número de casos de depressão acarreta um aumento na prescrição de medicação antidepressiva, sendo os Selective Serotonin Reuptake Inhibitors (SSRIs) mais prescritos a nível mundial.
A perda dentária pode agravar ainda mais os sintomas depressivos levando a uma diminuição da autoestima e isolamento social. No entanto, a reabilitação oral com implantes dentários é a solução mais atual e eficaz para restaurar a função mastigatória, a estética e a qualidade de vida dos pacientes. Para que haja um bom prognóstico do implante dentário, é necessário que ocorra o processo de osteointegração entre a
superfície do implante e o osso hospedeiro.
Porém, com o avançar dos anos e havendo cada vez mais estudos, foram detetadas evidências entre o uso de SSRIs e a perda de osteointegração de implantes. No qual foi destacado um aumento na taxa de falha de implantes dentários em pacientes medicados com SSRIs.
Esta monografia tem como objetivo estudar a osteointegração dos implantes dentários em pacientes medicados com SSRIs.
Para tal, foi realizada uma pesquisa na base de dados PUBMED de publicações científicas, incluindo artigos e livros com texto disponível em português, espanhol e inglês, com datas de publicação entre 2005 e 2022, considerando as referências dos mesmos.
Depression, a mental health condition, is a growing global concern due to its significant impact on people's quality of life, physical health, and emotional well-being. At the same time, there is an increasing rate of tooth loss due to neglect of oral health care combined with apathy resulting from depression. The rise in depression is leading to an increase in the prescription of antidepressants, with Selective Serotonin Reuptake Inhibitors (SSRIs) being the most prescribed worldwide. Tooth loss can exacerbate depressive symptoms, leading to low self-esteem and social isolation. However, oral rehabilitation with dental implants is the most modern and effective solution for restoring chewing function, aesthetics, and quality of life for patients. For dental implants to have a good prognosis, the process of osseointegration between the implant surface and the host bone must take place. However, over the years and with an increasing number of studies, a link has been found between the use of SSRIs and the loss of implant osseointegration. An increase in the failure rate of dental implants in patients taking SSRIs has been highlighted. The aim of this monograph is to investigate the osseointegration of dental implants in patients taking SSRIs. For this purpose, a search was carried out in the PUBMED database of scientific publications, including articles and books with text available in Portuguese, Spanish and English, with publication dates between 2005 and 2022, considering their references.
Depression, a mental health condition, is a growing global concern due to its significant impact on people's quality of life, physical health, and emotional well-being. At the same time, there is an increasing rate of tooth loss due to neglect of oral health care combined with apathy resulting from depression. The rise in depression is leading to an increase in the prescription of antidepressants, with Selective Serotonin Reuptake Inhibitors (SSRIs) being the most prescribed worldwide. Tooth loss can exacerbate depressive symptoms, leading to low self-esteem and social isolation. However, oral rehabilitation with dental implants is the most modern and effective solution for restoring chewing function, aesthetics, and quality of life for patients. For dental implants to have a good prognosis, the process of osseointegration between the implant surface and the host bone must take place. However, over the years and with an increasing number of studies, a link has been found between the use of SSRIs and the loss of implant osseointegration. An increase in the failure rate of dental implants in patients taking SSRIs has been highlighted. The aim of this monograph is to investigate the osseointegration of dental implants in patients taking SSRIs. For this purpose, a search was carried out in the PUBMED database of scientific publications, including articles and books with text available in Portuguese, Spanish and English, with publication dates between 2005 and 2022, considering their references.
Description
Dissertação para obtenção do grau de Mestre no Instituto Universitário Egas Moniz
Keywords
Osseointegration ou Osteointegration Dental implant Risk factors Epidemiology SSRI ou Selective serotonin reuptake inhibitor